Across TCGA pan-cancer cohorts, RNU6-806P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6-806P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNU6-806P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-806P is over-expressed in tumor, although a few such as STAD and KIRP show the opposite, repressed pattern.

STAD, PRAD, and KIRP are the cancer types where RNU6-806P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-806P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	−0.180	.016	2	view →
PRAD	All	All	+0.159	.038	2	view →
KIRP	Male	All	−0.120	.019	2	view →
ESCA	All	All	−0.542	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6-806P RNA expression & survival · all RNU6-806P data types